September 21, 2016
(Scientific American) – In my decade of teaching bioethics at Columbia University, I have always advocated for the application of five traditional guidelines to evaluate the ethics of an emerging biotechnology. These guidelines are: beneficence, maleficence, justice, autonomy, and respect for human dignity. Still, hovering in the back of my mind, there is another guideline to be considered called the “yuck factor.”
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.